Irene Dell’Anno - Search Results

Year	Number of Results
2017	1
2018	1
2019	1
2020	4
2021	2
2022	1
2023	5
2024	1

1

Pdta Net come strumento per l’analisi dei percorsi regionali delle malattie rare: l’esempio della fibrosi cistica.

Dell'Anno I, Calabria S, Dondi L, Ronconi G, Dondi L, Addesi A, Pedrini A, Esposito I, Maggioni AP, Martini N, Piccinni C. Dell'Anno I, et al. Recenti Prog Med. 2023 Sep;114(9):534-535. doi: 10.1701/4088.40801. Recenti Prog Med. 2023. PMID: 37530008 Italian. No abstract available.

2

Progress of malignant mesothelioma research in basic science: A review of the 14th international conference of the international mesothelioma interest group (iMig2018).

Wu L, Dell'Anno I, Lapidot M, Sekido Y, Chan ML, Kohno M, Serre-Beinier V, Felley-Bosco E, de Perrot M. Wu L, et al. Among authors: dell anno i. Lung Cancer. 2019 Jan;127:138-145. doi: 10.1016/j.lungcan.2018.11.034. Epub 2018 Nov 29. Lung Cancer. 2019. PMID: 30642542 Review.

3

A Drug Screening Revealed Novel Potential Agents against Malignant Pleural Mesothelioma.

Dell'Anno I, Melani A, Martin SA, Barbarino M, Silvestri R, Cipollini M, Giordano A, Mutti L, Nicolini A, Luzzi L, Aiello R, Gemignani F, Landi S. Dell'Anno I, et al. Cancers (Basel). 2022 May 20;14(10):2527. doi: 10.3390/cancers14102527. Cancers (Basel). 2022. PMID: 35626133 Free PMC article.

4

EIF4G1 and RAN as Possible Drivers for Malignant Pleural Mesothelioma.

Dell'Anno I, Barbarino M, Barone E, Giordano A, Luzzi L, Bottaro M, Migliore L, Agostini S, Melani A, Melaiu O, Catalano C, Cipollini M, Silvestri R, Corrado A, Gemignani F, Landi S. Dell'Anno I, et al. Int J Mol Sci. 2020 Jul 9;21(14):4856. doi: 10.3390/ijms21144856. Int J Mol Sci. 2020. PMID: 32659970 Free PMC article.

5

[Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].

Calabria S, Ronconi G, Dondi L, Piccinni C, Pedrini A, Dondi L, Dell'Anno I, Esposito I, Addesi A, Martini N, Maggioni AP. Calabria S, et al. Among authors: dell anno i. Recenti Prog Med. 2023 Feb;114(2):94-109. doi: 10.1701/3966.39449. Recenti Prog Med. 2023. PMID: 36700719 Italian.

6

Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.

Dell'Anno I, Martin SA, Barbarino M, Melani A, Silvestri R, Bottaro M, Paolicchi E, Corrado A, Cipollini M, Melaiu O, Giordano A, Luzzi L, Gemignani F, Landi S. Dell'Anno I, et al. Invest New Drugs. 2021 Jun;39(3):644-657. doi: 10.1007/s10637-020-01040-y. Epub 2020 Dec 9. Invest New Drugs. 2021. PMID: 33300108 Free PMC article.

7

Strategies for single base gene editing in an immortalized human cell line by CRISPR/Cas9 technology.

Corrado A, Aceto R, Miglietta S, Silvestri R, Dell'Anno I, Lepori I, Ricci B, Romei C, Giovannoni R, Poliseno L, Evangelista M, Vitiello M, Cipollini M, Elisei R, Landi S, Gemignani F. Corrado A, et al. Among authors: dell anno i. 3 Biotech. 2024 Feb;14(2):45. doi: 10.1007/s13205-023-03878-4. Epub 2024 Jan 19. 3 Biotech. 2024. PMID: 38261961 Free PMC article.

8

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).

Dell'Anno I, Barone E, Mutti L, Rassl DM, Marciniak SJ, Silvestri R, Landi S, Gemignani F. Dell'Anno I, et al. J Transl Med. 2020 Sep 4;18(1):341. doi: 10.1186/s12967-020-02487-6. J Transl Med. 2020. PMID: 32887638 Free PMC article.

9

[The population affected by neovascular age-related macular degeneration and treated with anti-Vegf through Italian administrative healthcare data.].

Calabria S, Ronconi G, Dondi L, Piccinni C, Pedrini A, Dondi L, Dell'Anno I, Esposito I, Addesi A, Staurenghi G, Bandello F, Ricci F, Martini N. Calabria S, et al. Among authors: dell anno i. Recenti Prog Med. 2023 Jul-Aug;114(7):447-461. doi: 10.1701/4062.40464. Recenti Prog Med. 2023. PMID: 37392108 Italian.

10

Pro64His (rs4644) Polymorphism Within Galectin-3 Is a Risk Factor of Differentiated Thyroid Carcinoma and Affects the Transcriptome of Thyrocytes Engineered via CRISPR/Cas9 System.

Corrado A, Aceto R, Silvestri R, Dell'Anno I, Ricci B, Miglietta S, Romei C, Giovannoni R, Poliseno L, Evangelista M, Vitiello M, Cipollini M, Garritano S, Giusti L, Zallocco L, Elisei R, Landi S, Gemignani F. Corrado A, et al. Among authors: dell anno i. Thyroid. 2021 Jul;31(7):1056-1066. doi: 10.1089/thy.2020.0366. Epub 2021 Mar 2. Thyroid. 2021. PMID: 33308024

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

14 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year